We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+18.03%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$271M
AUM Growth
+$85.9M
Cap. Flow
+$61M
Cap. Flow %
22.49%
Top 10 Hldgs %
30.66%
Holding
68
New
20
Increased
25
Reduced
11
Closed
9

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$6.64M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$5.6M
3
SNY icon
Sanofi
SNY
+$5.57M
4
CELG
Celgene Corp
CELG
+$5.25M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$3.72M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$7.6M
2
UNH icon
UnitedHealth
UNH
+$6.97M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$5.38M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.07M
5
ISRG icon
Intuitive Surgical
ISRG
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 92.84%
2 Energy 1.43%
3 Utilities 0.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCG
1
DELISTED
Wellcare Health Plans, Inc.
WCG
$9.44M 3.48%
35,000
+2,500
+8% +$646K
LLY icon
2
Eli Lilly
LLY
$1.04T
$9.08M 3.35%
70,000
+15,000
+27% +$1.82M
BSX icon
3
Boston Scientific
BSX
$69.2B
$8.64M 3.18%
225,000
+5,000
+2% +$191K
BAX icon
4
Baxter International
BAX
$14.1B
$8.54M 3.15%
105,000
+45,000
+75% +$3.28M
ABT icon
5
Abbott
ABT
$183B
$7.99M 2.95%
100,000
-15,000
-13% -$1.12M
HUM icon
6
Humana
HUM
$43.7B
$7.98M 2.94%
30,000
+10,000
+50% +$2.88M
DHR icon
7
Danaher
DHR
$140B
$7.92M 2.92%
67,680
+16,920
+33% +$1.73M
MRK icon
8
Merck
MRK
$317B
$7.9M 2.91%
99,560
– –
ELV icon
9
Elevance Health
ELV
$84.8B
$7.89M 2.91%
27,500
+5,000
+22% +$1.45M
HCA icon
10
HCA Healthcare
HCA
$88.7B
$7.82M 2.88%
60,000
+25,000
+71% +$3.36M
MOH icon
11
Molina Healthcare
MOH
$10.2B
$7.81M 2.88%
55,000
+25,000
+83% +$3.38M
NVO
12
Novo Nordisk
NVO
$197B
$7.06M 2.6%
+270,000
New +$6.64M
BIO icon
13
Bio-Rad Laboratories Class A
BIO
$9.31B
$6.11M 2.25%
20,000
+7,500
+60% +$2.02M
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
$6.08M 2.24%
+45,000
New +$5.6M
AZN icon
15
AstraZeneca
AZN
$250B
$6.07M 2.23%
75,000
+7,300
+11% +$575K
UHS icon
16
Universal Health Services
UHS
$10.4B
$6.02M 2.22%
45,000
+5,000
+13% +$658K
SYK icon
17
Stryker
SYK
$129B
$5.93M 2.18%
30,000
-5,000
-14% -$900K
SNY icon
18
Sanofi
SNY
$103B
$5.76M 2.12%
+130,000
New +$5.57M
ISRG icon
19
Intuitive Surgical
ISRG
$133B
$5.71M 2.1%
30,000
-10,500
-26% -$1.87M
CELG
20
DELISTED
Celgene Corp
CELG
$5.66M 2.09%
+60,000
New +$5.25M
ELAN icon
21
Elanco Animal Health
ELAN
$13.1B
$5.61M 2.07%
175,000
+91,363
+109% +$2.81M
VRTX icon
22
Vertex Pharmaceuticals
VRTX
$123B
$5.52M 2.03%
30,000
-5,000
-14% -$924K
TMO icon
23
Thermo Fisher Scientific
TMO
$214B
$5.47M 2.02%
20,000
+5,000
+33% +$1.24M
REGN icon
24
Regeneron Pharmaceuticals
REGN
$79.1B
$5.34M 1.97%
13,000
+3,000
+30% +$1.24M
INCY icon
25
Incyte
INCY
$24.3B
$5.16M 1.9%
60,000
+25,000
+71% +$2.03M
1
2 3

Similar funds

VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return
MFG
Macco Financial Group Green Bay, Wisconsin $132M AUM

Sivik Global Healthcare's Q1 2019 Portfolio in Review

As of Q1 2019, Sivik Global Healthcare held 68 positions worth $271M, up 46% from $186M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sivik Global Healthcare deployed $61M of net new capital in Q1 2019, opening 20 new positions and adding to 25 existing holdings. Its largest new stake was Novo Nordisk: 270,000 shares worth $7.06M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 91% a quarter earlier, followed by Energy and Utilities.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $1.87M trimmed.

  • Sivik Global Healthcare's largest Q1 2019 buy was Novo Nordisk: 270,000 shares worth $7.06M.
  • Sivik Global Healthcare added most to GW Pharmaceuticals Plc American Depositary Shares in Q1 2019, an estimated $3.72M increase.
  • Sivik Global Healthcare's biggest Q1 2019 reduction was Intuitive Surgical, cutting an estimated $1.87M.
  • Sivik Global Healthcare fully exited Cigna in Q1 2019, selling an estimated $7.6M.
  • Sivik Global Healthcare's ten largest holdings make up 31% of its $271M portfolio in Q1 2019.
  • Sivik Global Healthcare opened 20 new positions and closed 9 in Q1 2019.
  • Sivik Global Healthcare's portfolio value rose 46% quarter-over-quarter to $271M.

Based on Sivik Global Healthcare's 13F filing for Q1 2019, filed 8 May 2019.